BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soliman HM, Ghonaim GA, Gharib SM, Chopra H, Farag AK, Hassanin MH, Nagah A, Emad-Eldin M, Hashem NE, Yahya G, Emam SE, Hassan AEA, Attia MS. Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics. Int J Mol Sci 2021;22:10794. [PMID: 34639135 DOI: 10.3390/ijms221910794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Cano A, Muñoz-Morales Á, Sánchez-López E, Ettcheto M, Souto EB, Camins A, Boada M, Ruíz A. Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 2023;15. [PMID: 36678926 DOI: 10.3390/pharmaceutics15010298] [Reference Citation Analysis]
2 Ozansoy M, Mikati H, Velioglu HA, Yulug B. Exosomes: A missing link between chronic systemic inflammation and Alzheimer's disease? Biomed Pharmacother 2023;159:114161. [PMID: 36641928 DOI: 10.1016/j.biopha.2022.114161] [Reference Citation Analysis]
3 Kanojia N, Thapa K, Kaur G, Sharma A, Puri V, Verma N. Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease. Journal of Drug Delivery Science and Technology 2023;79:104074. [DOI: 10.1016/j.jddst.2022.104074] [Reference Citation Analysis]
4 Pasika SR, Bulusu R, Rao BVK, Kommineni N, Bolla PK, Kala SG, Godugu C. Nanotechnology for Biomedical Applications. Nanomaterials 2023. [DOI: 10.1007/978-981-19-7963-7_11] [Reference Citation Analysis]
5 Chauhan S, Behl T, Sehgal A, Singh S, Sharma N, Gupta S, Albratty M, Najmi A, Meraya AM, Alhazmi HA. Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer's Disease. Neurotox Res 2022;40:1758-73. [PMID: 36564606 DOI: 10.1007/s12640-022-00621-4] [Reference Citation Analysis]
6 Rajput A, Pingale P, Dhapte-pawar V. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Front Pharmacol 2022;13:979682. [DOI: 10.3389/fphar.2022.979682] [Reference Citation Analysis]
7 Picone P. Nanobiotechnology: A New Frontier for Brain Disorders. IJMS 2022;23:9603. [DOI: 10.3390/ijms23179603] [Reference Citation Analysis]
8 Wu J, Yuan M, Shen J, Chen Y, Zhang R, Chen X, Wang H, Yin Z, Zhang X, Liu S, Sun Q. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes. Phytomedicine 2022;103:154229. [PMID: 35691076 DOI: 10.1016/j.phymed.2022.154229] [Reference Citation Analysis]
9 Chopra H, Bibi S, Singh I, Kamal MA, Islam F, Alhumaydhi FA, Emran TB, Cavalu S. Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects. Front Aging Neurosci 2022;14:879114. [DOI: 10.3389/fnagi.2022.879114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gomes C, Sequeira C, Likhite S, Dennys CN, Kolb SJ, Shaw PJ, Vaz AR, Kaspar BK, Meyer K, Brites D. Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes. Cells 2022;11:1186. [DOI: 10.3390/cells11071186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ye M, Wang J, Pan S, Zheng L, Wang Z, Zhu X. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers. Molecular Therapy - Oncolytics 2022;24:101-113. [DOI: 10.1016/j.omto.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bhattacharya T, Soares GABE, Chopra H, Rahman MM, Hasan Z, Swain SS, Cavalu S. Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders. Materials (Basel) 2022;15:804. [PMID: 35160749 DOI: 10.3390/ma15030804] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 35.0] [Reference Citation Analysis]
13 Mishra N, Ashique S, Garg A, Rai VK, Dua K, Goyal A, Bhatt S. Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases. Drug Discov Today 2022:S1359-6446(22)00003-4. [PMID: 35017085 DOI: 10.1016/j.drudis.2022.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Ouerdane Y, Hassaballah MY, Nagah A, Ibrahim TM, Mohamed HAH, El-baz A, Attia MS. Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications. Pharmaceuticals 2022;15:76. [DOI: 10.3390/ph15010076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
15 Meldolesi J. News about Therapies of Alzheimer’s Disease: Extracellular Vesicles from Stem Cells Exhibit Advantages Compared to Other Treatments. Biomedicines 2022;10:105. [DOI: 10.3390/biomedicines10010105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]